Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DYNDYN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DYNE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 2.2M shares of DYN (DYNE THERAPEUTICS INC), worth $47.9M as of 2026-Q2. The position was increased (+25.2% shares). DYN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$47.9M

Current Shares

2.2M

Total Value Change

+$33.1M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+25.2%
$47.9M0.0%$22.21
36
2026-Q1
Decreased
1.7M
-24.5%
$31.2M0.0%$14.60
0
2025-Q4
Increased
2.3M
+20.1%
$44.7M0.0%$19.20
35
2025-Q3
Increased
1.9M
+41.8%
$24M0.0%$12.37
38
2025-Q2
Increased
1.3M
+34.7%
$12.8M0.0%$9.57
36
2025-Q1
Increased
994,886
+58.2%
$10.4M0.0%$11.45
40
2024-Q4
New
628,703
-
$14.8M0.0%$23.65
39

Other major holders of DYN: BlackRock, Inc., Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used